Suzhou Ribo Life Science Co., Ltd. - B - H Shares Stock: price and insider trades · Hong Kong
No insider purchase over the last 90 days. The latest, by GAN LIMING, was filed 13 Jul 2026.
Suzhou Ribo Life Science Co., Ltd. - B - H Shares: what insiders have been doing
This page follows insider dealings at Suzhou Ribo Life Science Co., Ltd. - B - H Shares as filed with HKEX, a company from the Health Care sector. The last twelve months, up to 23 October 2026, brought 3 filings signed by 1 insider.
Not one open-market sale was filed. On the buying side, 1 insider reported 3 purchases totalling €112k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The buyers include 1 senior executive. At €40k, the purchase published on 13 July 2026 by Gan Liming is the largest of the period.
The most recent open-market purchase was published on 13 July 2026, 118 days ago. Typically, a trade is published a median of 4 days after it takes place. Until a filing is published, the market cannot know about the trade.
With 3 filings in twelve months, the company is quieter than the median of 4 filings across the 1,315 companies we follow on the same exchange. The full history, which starts in 2026, counts 3 purchases against no sales.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and EssilorLuxottica. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleSince the insiders bought
- +9.5%Entry HK$242.91 · Close at T+90 HK$266.08
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Suzhou Ribo Life Science Co., Ltd. - B - H Shares Strong Buy (bullish), based on 6 analysts. Average price target: HK$100.65.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 6,800 shares@ HK$52.685935.8% of flowShareXHKGHKEX:DA20260713E00422Canonical exit: 7 Oct 2026 (T+90)
- 7,200 shares@ HK$45.966733.1% of flowShareXHKGHKEX:DA20260706E00432Canonical exit: 28 Sept 2026 (T+90)
- 6,000 shares@ HK$52.0031.2% of flowShareXHKGHKEX:DA20260706E00436Canonical exit: 1 Oct 2026 (T+90)
3 of 3 declarations
About Suzhou Ribo Life Science Co., Ltd. - B - H Shares
Suzhou Ribo Life Science Co., Ltd. is a biotechnology company focused on the development of health products. It is listed on the Hong Kong Stock Exchange under the H Shares symbol.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
